These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 11366864)

  • 1. Upcoming compassionate use programs for two new antiretrovirals will begin this fall.
    Schouten J
    STEP Perspect; 1999; 99(3):16. PubMed ID: 11366864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expanded access.
    Proj Inf Perspect; 1999 Sep; (28):8. PubMed ID: 11367366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expanded access program for ABT-378 under way.
    Slovick J
    Posit Living; 1999 Nov; 8(10):10. PubMed ID: 11367322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ABT-378 early access program begins.
    AIDS Treat News; 1999 Oct; (No 328):1-2. PubMed ID: 11366816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. French investigators warn of LPV/TDF/ddI interaction.
    Carter M
    IAPAC Mon; 2003 Dec; 9(12):315. PubMed ID: 15055164
    [No Abstract]   [Full Text] [Related]  

  • 6. ICAAC: new drugs in late breaker session.
    James JS
    AIDS Treat News; 1999 Oct; (No 328):3-5. PubMed ID: 11366817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tenofovir (PMPA) compassionate access study opens.
    AIDS Treat News; 1999 Nov; (No 330):1. PubMed ID: 11367168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on antivirals.
    Proj Inf Perspect; 1997 Jul; (22):7-9. PubMed ID: 11364579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Update on tenofovir (PMPA) compassionate access study.
    AIDS Treat News; 1999 Nov; (No 331):4. PubMed ID: 11367126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [First nucleotide analog against HIV. Lowers viral load also in drug resistance].
    MMW Fortschr Med; 2002 Aug; 144(33-34):60-1. PubMed ID: 12380157
    [No Abstract]   [Full Text] [Related]  

  • 11. [Tenofovir in Study 903. Also effective and tolerable in first-line therapy].
    MMW Fortschr Med; 2002 Aug; 144(33-34):61. PubMed ID: 12380158
    [No Abstract]   [Full Text] [Related]  

  • 12. ABT-387/r early access program expanded further.
    Res Initiat Treat Action; 1999 Dec; 5(5):22. PubMed ID: 11366887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tenofovir: Gilead applies for approval; expanded access liberalized.
    Gilden D
    AIDS Treat News; 2001 May; (364):2-3, 1. PubMed ID: 11569959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New drugs in development.
    Proj Inf Perspect; 1998 Sep; (25):8. PubMed ID: 11365851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential place of tenofovir in antiretroviral treatment regimens.
    Gazzard BG
    Int J Clin Pract; 2001 Dec; 55(10):704-9. PubMed ID: 11777298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gilead sciences releases Viread.
    Giles C
    Surviv News (Atlanta Ga); 2002 Jan; ():15. PubMed ID: 11870987
    [No Abstract]   [Full Text] [Related]  

  • 18. Tenofovir: FDA hearing October 3, public comment deadlines September 26.
    James JS
    AIDS Treat News; 2001 Aug; (370):3-4. PubMed ID: 11570163
    [No Abstract]   [Full Text] [Related]  

  • 19. More trouble for adefovir.
    Gilden D
    GMHC Treat Issues; 1999 Apr; 13(4):3. PubMed ID: 11366975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tenofovir DF expanded access. Criteria for U.S. program.
    AIDS Treat News; 2001 Feb; (360):2-3. PubMed ID: 12173565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.